Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling

Nature Immunology

Volumn 7, Issue 9, 2006, Pages 962-970

  Yamamoto, Masahiro ^a   Okamoto, Toru ^a   Takeda, Kiyoshi ^b   Sato, Shintaro ^c   Sanjo, Hideki ^a   Uematsu, Satoshi ^a   Saitoh, Tatsuya ^a,d   Yamamoto, Naoki ^d   Sakurai, Hiroaki ^e   Ishii, Ken J ^c   Yamaoka, Shoji ^d   Kawai, Taro ^c   Matsuura, Yoshiharu ^a   Takeuchi, Osamu ^a,c   Akira, Shizuo ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12P40; INTERLEUKIN 6; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; POLYUBIQUITIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME UBC13 E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MAMMAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; B-LYMPHOCYTES; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE KINASE KINASES; MICE; MICE, MUTANT STRAINS; MUTATION; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 33747615237     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1367     Document Type: Article

References (57)

1. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
2. Weil, R. & Israel, A. T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes. Curr. Opin. Immunol. 16, 374-381 (2004).
3. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
4. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
5. Kobayashi, T., Walsh, M.C. & Choi, Y. The role of TRAF6 in signal transduction and the immune response. Microbes Infect. 6. 1333-1338 (2004).
6. Chung, J.Y., Park, Y.C., Ye, H. & Wu, H. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115, 679-688 (2002).
7. Lin, X. & Wang, D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin. Immunol. 16, 429-435 (2004).
8. Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33-42 (2001).
9. Ruland, J., Duncan, G.S., Wakeham, A. & Mak, T.W. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19, 749-758 (2003).
10. Jun, J.E. et al. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18, 751-762 (2003).
11. Hara, H. et al. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18, 763-775 (2003).
12. Egawa, T. et al. Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation. Curr. Biol. 13, 1252-1258 (2003).
13. Ruefli-Brasse, A.A., French, D.M. & Dixit, V.M. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581-1584 (2003).
14. Newton, K. & Dixit, V.M. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13, 1247-1251 (2003).
15. Sun, L., Deng, L., Ea, C.K., Xia, Z.P. & Chen. Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301 (2004).
16. Deng, L. et al. Activation at the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
17. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
18. Shim, J.H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681 (2005).
19. Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095 (2005).
20. Spence, J., Sadis, S., Haas, A.L. & Finley, D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol. Cell. Biol. 15, 1265-1273 (1995).
21. Pickart, C.M. & Fushman, D. Polyubiquitin chains: Polymeric protein signals. Curr. Opin. Chem. Biol. 8, 610-616 (2004).
22. Hofmann, R.M. & Pickart, C.M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 96, 645-653 (1999).
23. Muralidhar, M.G. & Thomas, J.B. The Drosophila bendless gene encodes a neural protein related to ubiquitin-conjugating enzymes. Neuron 11, 253-266 (1993).
24. Zhou, H. et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature 427, 167-171 (2004).
25. Zhou, R. et al. The role of ubiquitination in Drosophila innate immunity. J. Biol. Chem. 280, 34048-34055 (2005).
26. Andersen, P.L. et al. Distinct regulation of Ubc13 functions by the two ubiquitin-conjugating enzyme variants Mms2 and Uev1A. J. Cell Biol. 170, 745-755 (2005).
27. Zhou, H., Du, M.Q. & Dixit, V.M. Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphome is linked to deregulated ubiquitin ligase activity. Cancer Cell 7, 425-431 (2005).
28. Habelhah, H. et al. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-κB. EMBO J. 23, 322-332 (2004).
29. Kobayashi, N. et al. Segregation at TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20, 1271-1280 (2001).
30. Gohda, J., Matsumura, T. & Inoue, J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/ IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF- dependent pathway in TLR signaling. J. Immunol. 173, 2913-2917 (2004).
31. Xue, L. et al. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4, 857-865 (2003).
32. Hayden, M.S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195-2224 (2004).
33. Chen, Z.J. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765 (2005).
34. Carter, A.B., Monick, M.M. & Hunninghake, G.W. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am. J. Respir. Cell Mol. Biol. 20, 751-758 (1999).
35. Scherle, P.A. et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J. Immunol. 161, 5681-5686 (1998).
36. Zhang, Y. et al. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430, 793-797 (2004).
37. Shinohara, H. et al. PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J. Exp. Med. 202, 1423-1431 (2005).
38. Shi, C.S. & Kehrl, J.H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278, 15429-15434 (2003).
39. Geetha, T., Kenchappa, R.S., Wooten, M.W. & Carter, B.D. TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J. 24, 3859-3868 (2005).
40. Courtois, G., Whiteside, S.T., Sibley, C.H. & Israel, A. Characterization of a mutant cell line that does not activate NF-κB in response to multiple stimuli. Mol. Cell. Biol. 17, 1441-1449 (1997).
41. Krappmann, D., Patke, A., Heissmeyer, V. & Scheidereit, C. B-cell receptor- and phorbol ester-induced NF-κB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's. Mol. Cell. Biol. 21, 6640-6650 (2001).
42. Leonardi, A., Chariot, A., Claudio, E., Cunningham, K. & Siebenlist, U. CIKS, a connection to IκB kinase and stress-activated protein kinase. Proc. Natl. Acad. Sci. USA 97, 10494-10499 (2000).
43. Li, X. et al. Act1, an NF-κB-activating protein. Proc. Natl. Acad. Sci. USA 97, 10489-10493 (2000).
44. Qian, Y. et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21, 575-587 (2004).
45. Pasparakis, M., Schmidt-Supprian, M. & Rajewsky, K. IκB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196, 743-752 (2002).
46. Li, Z.W., Omori, S.A., Labuda, T., Karin, M. & Rickert, R.C. IKKβ is required for peripheral B cell survival and proliferation. J. Immunol. 170, 4630-4637 (2003).
47. Chen, Z. et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586-1597 (1995).
48. Duncan, L.M. et al. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25, 1635-1645 (2006).
49. Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640-643 (2003).
50. Singhirunnusorn, P., Suzuki, S., Kawasaki, N., Saiki, I. & Sakurai, H. Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J. Biol. Chem. 280, 7359-7368 (2005).
51. Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240 (1998).
52. Schmidt-Supprian, M. et al. NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol. Cell 5, 981-992 (2000).
53. Rickert, R.C., Roes, J. & Rajewsky, K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318 (1997).
54. Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
55. Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144-1150 (2003).
56. Pomerantz, J.L., Denny, E.M. & Baltimore, D. CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex. EMBO J. 21, 5184-5194 (2002).
57. Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218-222 (2004).